MétaCan
Menu
← Back to cohort
Record W4416273858 · doi:10.1016/j.chest.2025.11.013

Applying Precision Medicine to the Heterogeneity of Asthma Attacks

2025· article· en· W4416273858 on OpenAlexafffund
C.A. Celis-Preciado, Elsa Ben Hamou Kuijpers, Sanjay Ramakrishnan, Imran Howell, Michael Wechsler, Praveen Akuthota, Simon Couillard

Bibliographic record

VenueCHEST Journal · 2025
Typearticle
Languageen
FieldMedicine
TopicAsthma and respiratory diseases
Canadian institutionsUniversité de Sherbrooke
FundersNIHR Oxford Biomedical Research CentreGenentechFaculté de médecine et des sciences de la santé, Université de SherbrookeBritish Medical AssociationNational Institute for Health and Care ResearchCanadian Lung AssociationIncyteRegeneron PharmaceuticalsFonds de Recherche du Québec - SantéCanadian Allergy, Asthma and Immunology FoundationAmgenCanadian Thoracic SocietySanofiAstraZenecaEli Lilly and CompanyGlaxoSmithKlineCelldex TherapeuticsUniversité de Sherbrooke
KeywordsPrecision medicineAsthmaAsthma exacerbationsExacerbationAsthma managementClinical Practice

Abstract

fetched live from OpenAlex

TOPIC IMPORTANCE: The standard of care for management of asthma attacks has remained unchanged for 70 years, relying on a symptom-based, severity-stratified approach. Severe asthma attacks are defined by a worsening of asthma requiring oral corticosteroid (OCS) treatment for unresolved symptoms for at least 48 hours, decreased lung function, or both. The 1-size-fits-all strategy with OCS treatment overlooks the biological mechanisms driving attacks and may lead to suboptimal outcomes. Importantly, OCS-related toxicities lead to significant morbidity, and cumulative OCS use has been associated with increased mortality. Antibiotics, often used indiscriminately, also increase adverse events and antimicrobial resistance. REVIEW FINDINGS: Recent studies have highlighted the heterogeneity of asthma attacks across clinical, etiologic, and therapeutic dimensions. Biomarker-informed assessments using blood eosinophils, exhaled nitric oxide (Feno), and point-of-care microbial molecular testing have improved the evaluation of attacks. Observational studies and trials have explored biomarker-guided management to reduce OCS and antibiotic use, potentially improving outcomes. Distinct inflammatory and OCS response profiles were identified in patients receiving biologics, emphasizing the complexity of attacks and the importance of residual (untreated) type 2 inflammatory pathways. Studies of the airway microbiome revealed that microbial dysbiosis is associated with clinical and inflammatory clusters. SUMMARY: Asthma attacks are complex episodes with diverse causes, endotypes, and phenotypes. Emerging evidence supports incorporating biomarkers (blood eosinophils, Feno, and microbial testing) into clinical assessment to refine management. Recent evidence expands our understanding of exacerbation mechanisms, highlighting the need for tailored management strategies. Recognizing asthma heterogeneity could shift care toward precision medicine, reducing OCS reliance and improving patient outcomes.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.012
metaresearch head score (Gemma)0.041
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.012
Threshold uncertainty score0.062

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0120.041
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0040.003
Bibliometrics0.0050.003
Science and technology studies0.0010.003
Scholarly communication0.0050.004
Open science0.0020.003
Research integrity0.0030.005
Insufficient payload (model declined to judge)0.0050.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.027
GPT teacher head0.341
Teacher spread0.315 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueCHEST Journal→Same topicAsthma and respiratory diseases→French-language works237,207→